HomeNAVB • OTCMKTS
add
Navidea Biopharmaceuticals Inc
Previous close
$0.00020
Day range
$0.050 - $0.050
Market cap
5.00M USD
Avg Volume
6.81K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.13M | — |
Net income | -2.26M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.10M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.86M | — |
Total assets | 5.70M | — |
Total liabilities | 8.68M | — |
Total equity | -2.98M | — |
Shares outstanding | 99.99M | — |
Price to book | -0.01 | — |
Return on assets | -76.56% | — |
Return on capital | 912.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -2.26M | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1983
Headquarters
Website
Employees
11
